等待開盤 03-27 09:30:00 美东时间
-15.385
-3.82%
HII names Christie Miller and Christian Ortego as Newport News Shipbuilding vice presidents HII named Christie Miller vice president of communications at its Newport News Shipbuilding division, effective April 1. Miller most recently served as director of communications at Newport News Shipbuilding
03-24 22:37
Citi has updated its return-on-equity trend baskets. "We created the ROE Trend Baskets which focus on forward ROE improvement driven by improving margins and higher total asset turnover, not financial...
03-22 21:54
HII Newport News Shipbuilding hosts Apprentice School commencement with Education Secretary Linda McMahon address HII’s Newport News Shipbuilding will host commencement exercises for the Newport News Shipbuilding Apprentice School’s class of 2025 at 10 a.m. on March 21 in Hampton, Virginia. U.S. Sec
03-16 22:00
今日重点评级关注:HC Wainwright & Co.:维持BridgeBio Oncology"买入"评级,目标价从27美元升至29美元;韦德布什:维持WAVE Life Sciences"跑赢大市"评级,目标价从33美元升至35美元
03-09 11:47
TD Cowen analyst Gautam Khanna maintains Huntington Ingalls Indus (NYSE:HII) with a Buy and raises the price target from $440 to $460.
03-07 00:41
HII Ingalls Shipbuilding Authenticates Keel of USS Philadelphia (LPD 32) Huntington Ingalls Industries’ Ingalls Shipbuilding division authenticated the keel for the future USS Philadelphia (LPD 32), a Flight II San Antonio-class amphibious transport dock ship. The ceremony included ship sponsor Maur
03-04 09:30
Goldman Sachs Research analysts updated their U.S. conviction list Monday as the new month kicked off, adding ConocoPhillips (COP) and Loar Holdings (LOAR) while removing Huntington Ingalls Industries...
03-03 04:43
Lawmakers from both parties are urging the Navy to move ahead with long delayed contracts for at least 15 submarines, warning that further holdups could damage the highly specialized industrial base t...
02-26 02:04
Here's a look at some of the firms with a "license to hunt" for a piece of one of the largest defense contracts in U.S. history.
02-25 01:21
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从39美元升至47美元;HC Wainwright & Co.:维持Agios制药"买入"评级,目标价从62美元升至65美元
02-13 15:30